Well constructed and balanced argument.The only way this plays...

First 247 Last

Share
Profile

Follow
brick6

588 Posts.

167

12/03/24

17:23

Post #: 72854713
Share

Originally posted by Shortblack: ↑

I bought into PET during the big hype. Just a very small investment to initially dip my toes in to see what might happen, because when things look too good to be true, they usually are.
When the lid was lifted on the corruption, illigalities, manipulations and bogus representations, I got out as quick as I could. The die hard, long term PET investors were very much like some of the AKP investors here. They spent a long time in denial and refused to let go of the dream they had been sold. Some of them still hold onto it. It becomes cult like.

ASIC and the Australian Federal Police are both still investigating PET. No charges have yet been laid and no legal actions have yet been commenced. So we'll have to wait and see how much power a certain group have over regulators and authorities.

When FB popped up to make his move to take control of PET I became curious about AKP and it didn't take much effort to clearly see the trouble they were in. There is no other obvious or probable reason for FBs interest in PET other than its bank balance. I honestly thought he would have made his move on the cash by now, but there is still a few weeks to go, so let's see if he dares.

It only took a little bit longer to see how similar the set up is to PET. The incredibly amatuerish and unprofessional way in which they manage the business; present their corporate identity; the outlandish representations they publish, full of excessive meaningless detail and flowery language and hope. You only have to compare their 2002 style website with other companies out there in the MEM Audio market - it's laughable.

This group of corporate buddies run together. If you look at the histories of the companies they have been involved in you will see who they all are.
They are predators. They have other ties outside of the corporate world that I won't mention here. I have little doubt they all have the same corporate lawyer.

Here's the MO. They find a listed entity with an idea or product in development, they take control and then they work on the hype and pump. They target particular types of investors, the ones that easily fall prey to flowerly language full of hope and promises, who lack the skills to properly research what's being presented; or are not skilled in analysing financial reports; or have little knowledge of the technicalities of the product and what would logically be needed to succeed in a specific market.
The hype is constant and they work with promoters like Graeme Newing who a lot of older investors follow for tips and recommendations (God only knows why).

By getting the share price pumped, they all massively increase their personal net worth, which over a period of time allows them to achieve far greater gains than any loss they may incur at the end of the day.

It is predatory behaviour. And I will be hanging around to see how it all ends.

Expand

Well constructed and balanced argument.

The only way this plays out well for the faithful is our sucess aligning with managements (FB).

The chances of retail getting a trouncing is high as you have highlighted, lets hope everyone gets a win.

AKP Price at posting: $6.20 Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 202 more messages in this thread...

First 247 Last

Add AKP (ASX) to my watchlist

(20min delay)
Last $6.20		Change 0.000(0.00%)		Mkt cap ! $181.1M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Well constructed and balanced argument.The only way this plays...

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Featured News

Well constructed and balanced argument.The only way this plays...

Top Stories

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Featured News